Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.
- DOI
- 10.1016/s0735-1097(00)00988-8
- Published
- 2000 Dec
- Container
- Journal of the American College of Cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0735-1097-00-00988-8,
title = {Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.},
author = {Laham RJ and Chronos NA and Pike M and Leimbach ME and Udelson JE and Pearlman JD and Pettigrew RI and Whitehouse MJ and Yoshizawa C and Simons M},
year = {2000},
journal = {Journal of the American College of Cardiology},
doi = {10.1016/s0735-1097(00)00988-8},
url = {https://doi.org/10.1016/s0735-1097(00)00988-8}
}RIS
TY - JOUR TI - Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. AU - Laham RJ AU - Chronos NA AU - Pike M AU - Leimbach ME AU - Udelson JE AU - Pearlman JD AU - Pettigrew RI AU - Whitehouse MJ AU - Yoshizawa C AU - Simons M PY - 2000 JO - Journal of the American College of Cardiology DO - 10.1016/s0735-1097(00)00988-8 UR - https://doi.org/10.1016/s0735-1097(00)00988-8 ER -
APA
RJ, L., NA, C., M, P., ME, L., JE, U., JD, P., RI, P., MJ, W., C, Y., & M, S. (2000). Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(00)00988-8
Source records
- pubmed · retrieved 2026-09-26T10:14:53.833Z